The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Rate of durable complete response in ALL, NHL, and CLL after immunotherapy with optimized lymphodepletion and defined composition CD19 CAR-T cells.
 
Cameron John Turtle
Consulting or Advisory Role - Juno Therapeutics; Seagen
Research Funding - Juno Therapeutics; Juno Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Juno Therapeutics
 
Laila-Aicha Hanafi
No Relationships to Disclose
 
Carolina Berger
Patents, Royalties, Other Intellectual Property - Juno Therapeutics
 
Theodore Gooley
No Relationships to Disclose
 
Colette Chaney
No Relationships to Disclose
 
Sindhu Cherian
No Relationships to Disclose
 
Lori Soma
No Relationships to Disclose
 
Xueyan Chen
No Relationships to Disclose
 
Cecilia CS Yeung
Research Funding - Gilead Sciences
 
Keith Loeb
No Relationships to Disclose
 
Brent L. Wood
No Relationships to Disclose
 
Michael Hudecek
Patents, Royalties, Other Intellectual Property - Juno Therapeutics
 
Daniel Sommermeyer
No Relationships to Disclose
 
Daniel Li
Employment - Juno Therapeutics
Leadership - Gilead Sciences; Juno Therapeutics
Stock and Other Ownership Interests - Juno Therapeutics
Patents, Royalties, Other Intellectual Property - Juno Therapeutics
 
Kevin Anthony Hay
No Relationships to Disclose
 
Shelly Heimfeld
No Relationships to Disclose
 
Stanley R. Riddell
Stock and Other Ownership Interests - Juno Therapeutics
Consulting or Advisory Role - Adaptive Biotechnologies; Cell Medica
Research Funding - Juno Therapeutics
Patents, Royalties, Other Intellectual Property - Juno Therapeutics
 
David G. Maloney
Honoraria - Celgene; Janssen; Roche; Seagen; Spectrum Pharmaceuticals
Consulting or Advisory Role - Juno Therapeutics
Research Funding - Juno Therapeutics